Skip to main content
Clinical Trials/CTRI/2024/07/069725
CTRI/2024/07/069725
Not yet recruiting
Phase 2

Comparative clinical evaluation of Sharbat-e-Toot Siyah and its sugarfree dosage form in the management of Warm-e-Halaq Muzmin (Chronic Pharyngitis) - WHM

Jamia Hamdard0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Jamia Hamdard
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Diagnosed patients of chronic pharyngitis (Pharyngitis more than 3 months) presenting with all OR more than three of the following signs and symptoms
  • Sore throat
  • Foreign body sensation
  • Burning sensation
  • Hoarseness of voice
  • Pharyngeal itching
  • Posterior pharyngeal wall hypertrophy

Exclusion Criteria

  • 1\)Age below 18 and above 65 years
  • 2\)Pregnant and lactating women
  • 3\)Congenital malformations of oropharynx
  • 4\)Diabetes mellitus
  • 5\)Oral candidiasis
  • 6\)Unwilling to participate in the study
  • 7\)Epiglottitis, Thyroiditis
  • 8\)Retropharyngeal abscess/peritonsillar abscess
  • 9\)Dental Sepsis
  • 10\)Carcinoma of throat

Outcomes

Primary Outcomes

Not specified

Similar Trials